MedTrace Logo

Dissolved Oxygen Dressing to Improve Chronic Wound Healing After Revascularization for Critical Limb Ischemia

NCT02046226 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 7

Last updated 2015-10-12

Study results available
· View outcomes & findings →

Summary

A Prospective, Randomized, Single-center Pilot Study of The OxyGenesys(TM) Dissolved Oxygen Dressing to Improve Chronic Wound Healing after REvascularization for Critical Limb Ischemia.

Conditions

  • Critical Limb Ischemia

Interventions

DEVICE

Oxygenesys(TM) Dissolved Oxygen Dressing

OxyGenesys(TM) Dissolved Oxygen Dressing

Sponsors & Collaborators

  • Yale University

    collaborator OTHER

  • Halyard Health

    lead INDUSTRY

Principal Investigators

  • Carlos Mena-Hurtado, MD · Yale University

  • David T Curd, MS · Kimberly-Clark Corporation

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2014-05-31
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02046226 on ClinicalTrials.gov